Leonteq Securities AG’s OptimizeRx OPRX Stock Holding History

Leonteq Securities AG’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$795	Hold	139	–	–	﹤0.01%	1190
2026 Q1	$873	Hold	139	–	–	﹤0.01%	1199
2025 Q4	$1.7K	Hold	139	–	–	﹤0.01%	1324
2025 Q3	$2.85K	Buy	+139	New	+$2.21K	﹤0.01%	1203
2023 Q2	–	Sell	-304	Closed	-$4.45K	–	1291
2023 Q1	$4.45K	Sell	304 -25	-8%	-$418	﹤0.01%	1106
2022 Q4	$5.53K	Hold	329	–	–	﹤0.01%	1126
2022 Q3	$4.88K	Hold	329	–	–	﹤0.01%	1131
2022 Q2	$9.01K	Sell	329 -29	-8%	-$859	﹤0.01%	1097
2022 Q1	$13.5K	Hold	358	–	–	﹤0.01%	1065
2021 Q4	$22.2K	Hold	358	–	–	﹤0.01%	1024
2021 Q3	$30.6K	Buy	+358	New	+$22.5K	﹤0.01%	909

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Leonteq Securities AG's OPRX Position: Q2 2026 in Review

Leonteq Securities AG held its OptimizeRx (OPRX) position steady in Q2 2026 at 139 shares worth $795. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Leonteq Securities AG first reported a position in OPRX in Q3 2021 and has held it in 11 quarters since. The position peaked at $30.6K in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Leonteq Securities AG held 139 shares of OptimizeRx worth $795 as of Q2 2026.
Leonteq Securities AG left its OptimizeRx share count unchanged in Q2 2026.
OptimizeRx made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1190 holding.
Leonteq Securities AG first reported a position in OptimizeRx in Q3 2021 and has held it in 11 quarters since.
Leonteq Securities AG's OptimizeRx position peaked at $30.6K in Q3 2021.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.